Propanc Biopharma
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6 Butler St U 302, Camberwell, Victoria,...Phone Number
+61398820780Website
www.propanc.comRevenue
-Stock Symbol
PPCBIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Propanc Biopharma
Propanc Biopharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Camberwell, Victoria, Australia, focused on developing novel treatments for patients with pancreatic, ovarian, and colorectal cancers. The company's lead product candidate, PRP, is an enhanced pro-enzyme formulation designed to work synergistically to target and eradicate cancer stem cells, aiming to prevent tumor recurrence and metastasis in high-risk cancer survivors. Rather than solely targeting tumor cell death, Propanc's approach focuses on inducing cell differentiation, encouraging malignant cells to stop proliferating. It maintains research collaborations with academic institutions to advance its pipeline, with PRP progressing toward a planned First-In-Human clinical study.Explore more
Propanc Biopharma Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Propanc Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Propanc Biopharma
Propanc Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Propanc Biopharma is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Propanc Biopharma had a recent Job posting/layoffs
Check if Propanc Biopharma has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Propanc Biopharma recently announced quarterly report
Product Launch: Get notified when Propanc Biopharma launches new products
Funding: Get notified immidiatlly once Propanc Biopharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Propanc Biopharma
Find more new buyers
Compare Similar Companies to Propanc Biopharma
Compare insights from companies similar to Propanc Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Propanc Biopharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Propanc Biopharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Propanc Biopharma.
Propanc Biopharma financials insights
Gather financial insights about Propanc Biopharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$1.2M
2020
Private Equity
$3M
2021
Private Equity
$5M
2025
Other Financing Round
$100M
Propanc Biopharma Tech Stack
A closer look at the technologies used by Propanc Biopharma
Most Recent Scoops
Funding
Propanc Biopharma Inc has secured $100 million in additional funding from investor Hexstone capital.
Funding
New Hire
Executive Move
Executive Moves, New Hire
Event
Events
Event
Events
Project
Funding
Propanc Biopharma News & Media
Propanc Biopharma Initiates $5.0 Million Share Repurchase Program
"We feel strongly about undertaking important corporate actions that reflect the true value of our shareholders’ equity."Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study
"Visting our CDMO partner provides tremendous benefits being able to visualize future cGMP production of PRP"Propanc Biopharma Authorizes $5.0 Million Share Repurchase Program
"The foundation is clearly there and as a result, we believe we are undervalued significantly,” said Mr. James Nathanielsz, Propanc’s CEOPropanc Biopharma’s CEO Attends Keynote Address, “Rejuvenation and Health: Science for an Ageing Society,” at the University of Granada, Spain
It was an honor to attend the keynote address of Dr. Izpisúa whose scientific interests and vision for the future of humanity are world renowned
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Propanc Biopharma
Sign Up For FreeTo access detailed company insights
Propanc Biopharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Camberwell, Victoria, Australia, focused on developing novel treatments for patients with pancreatic, ovarian, and colorectal cancers. The company's lead product candidate, PRP, is an enhanced pro-enzyme formulation designed to work synergistically to target and... Read More
